FIELD: medicine.
SUBSTANCE: invention refers to medicine, oncology and concerns a method of treating locally advanced rectal cancer (RC). One performs teletherapy (RTT), chemotherapy capecitabine and oxaliplatin, verified chemotherapy followed by a surgery. Note here that conformable large fraction RTT is performed in a single basic dose of 4 Gy to total basic dose of 40 Gy, 3 times a week, total 10 sessions. Simultaneously with the course of radiation therapy, a course of chemotherapy capecitabine in dosage 850 mg/m2 twice a day every 12:00. Then 2 courses of consolidating chemotherapy every 7 days: oxaliplatin in dosage 130 mg/m2 intravenously on the first day of each course and capecitabine in a daily dose 2,000 mg/m2 inside twice a day every 12:00 during 14 days. Total duration of treatment of 8 weeks.
EFFECT: method provides evident therapeutic pathomorphosis at T3 and T4 stages of RC, increase of frequency of complete therapeutic pathomorphism, low degree of toxicity.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ORGAN-PRESERVING TREATMENT OF OPERABLE RECTAL CANCER | 2020 |
|
RU2740361C1 |
METHOD OF TREATING RECTAL CANCER | 2009 |
|
RU2414936C1 |
METHOD OF TREATING RECTAL CANCER | 2011 |
|
RU2477641C1 |
METHOD OF TREATING RECTAL CANCER USING A PERSONALIZED APPROACH | 2018 |
|
RU2701143C1 |
METHOD OF COMBINATION TREATMENT OF LOCALLY ADVANCED RECTAL CANCER | 2015 |
|
RU2599043C1 |
METHOD OF COMBINATION TREATMENT OF LOCALLY ADVANCED RECTAL CANCER | 2010 |
|
RU2447914C1 |
METHOD OF TREATING RECTAL CANCER WITH SYNCHRONOUS REMOTE METASTASES | 2011 |
|
RU2453345C1 |
METHOD OF NEOADJUVANT THERMOCHEMORADIATION TREATMENT OF RECTAL CANCER | 2018 |
|
RU2704205C2 |
METHOD FOR COMBINED TREATMENT OF PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER USING NEOADJUVANT RADIATION THERAPY AND CONSOLIDATING CHEMOTHERAPY | 2021 |
|
RU2770989C2 |
METHOD OF TREATING SQUAMOUS CELL CANCER OF ANAL CANAL | 2015 |
|
RU2581919C1 |
Authors
Dates
2016-03-27—Published
2015-03-26—Filed